NCT00047567终止4 期
Open-label Adjunctive Zonisamide for Bipolar Disorder
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 终止
- 入组人数
- 20
研究概览
简要总结
To study the safety and efficacy of zonisamide as adjunctive therapy for children and adolescents with bipolar I or II disorder.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 6 Years 至 17 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Bipolar I/II
- •Average intelligence
- •Taking at least one, but no more than two mood stabilizers
排除标准
- 未提供
研究者
相似试验
已完成
3 期
Evaluating the Efficacy and Safety of Zonisamide in the Treatment of Partial SeizuresPartial SeizuresNCT00327717Eisai Inc.240
终止
3 期
Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures Associated With Idiopathic Generalised EpilepsyEpilepsyNCT00693017Eisai Limited10
已完成
4 期
Open-label, Multi-center Trial of Zonisamide as Adjunctive Therapy in Patients With Uncontrolled Partial EpilepsyEpilepsyNCT01140867Eisai Korea Inc.121
已完成
3 期
A Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Extension Study)Partial SeizuresNCT01136954Eisai Limited144
已完成
3 期
A Study of Zonisamide to Prevent Olanzapine-Associated Weight GainWeight GainNCT00363376Lindner Center of HOPE42